Selected research from leading health care experts whose findings have a direct bearing on public policies effecting medical progress. Research is chosen based on its quality and relevance by the Medical Progress Today editorial staff.

Selected Research

Assessment of Beneficiary Savings in the Medicare Drug Discount Card Program
The Lewin Group, 8-12-04

This study, conducted by the health care consulting firm The Lewin Group for the Healthcare Leadership Council, compared average savings for Medicare beneficiaries who shopped at retail pharmacies with the Medicare drug discount card to the retail prices they would have faced without the card. The study found that, nationally, the best discount cards offered about a 20% discount ($10 per prescription) to beneficiaries, with more than half of the cards offering savings of 17%.

This would mean that, for the life of the discount card program (until 2006, about 18 months) the best cards would offer savings of approximately $850 over retail prices. Per capita savings for low-income beneficiaries using the discount card (including the available $600 subsidy) would be over $1,500.

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000